A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU.
about
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-AnalysesTrends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.Escherichia coli Peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center.Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.Clinical and Molecular Characteristics of Neonatal Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan.Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent OrganismsThe epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.Multidrug-resistant Escherichia coli in Asia: epidemiology and management.Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant.Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections.
P2860
Q26781236-B6099811-E94B-4650-A289-39242B7443D3Q30354148-BC9D4F2A-B248-4082-8A6A-3A78DCD13D6BQ33660340-48CE68BD-E06B-45B3-A75E-2CFCBD0CE5E6Q35589184-A0BB2545-D0F7-4205-AFC9-D9707A1A1DF4Q36098932-476ABF7F-91CA-4B86-8F5F-98CCCBEF6A88Q36730158-00FF1A25-B1AD-40C5-A6B7-07C8B9F5D3B7Q37408471-295BCDC4-D4DE-48B3-910B-F9BA67F12248Q38389612-A7ADCE3B-A45B-4A8D-BA84-AEF3382F7720Q51561730-434D54E1-D67D-48CD-9340-14CC042F707AQ54248806-DADEA6A1-3CD9-4FBC-889D-26514EC78B4E
P2860
A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A 7-year surveillance for ESBL ...... crease of CTX-M-15 in the ICU.
@en
A 7-year surveillance for ESBL ...... crease of CTX-M-15 in the ICU.
@nl
type
label
A 7-year surveillance for ESBL ...... crease of CTX-M-15 in the ICU.
@en
A 7-year surveillance for ESBL ...... crease of CTX-M-15 in the ICU.
@nl
prefLabel
A 7-year surveillance for ESBL ...... crease of CTX-M-15 in the ICU.
@en
A 7-year surveillance for ESBL ...... crease of CTX-M-15 in the ICU.
@nl
P2093
P2860
P1476
A 7-year surveillance for ESBL ...... crease of CTX-M-15 in the ICU.
@en
P2093
P2860
P304
P356
10.1017/S0950268809990409
P577
2009-07-21T00:00:00Z